Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea · Delayed Price · Currency is KRW 59,200
-5,800 (-8.92%)
Sep 1, 2026, 3:30 PM KST
Orum Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 18,511 | -41,969 | -5,740 | 68,217 | -63,319 |
Depreciation & Amortization | 3,286 | 3,297 | 2,868 | 1,771 | 1,290 |
Other Amortization | - | - | - | 824.72 | 799.07 |
Loss (Gain) From Sale of Assets | 61.17 | 4.13 | - | -205.25 | - |
Loss (Gain) From Sale of Investments | 2,860 | -2,906 | -799.27 | 809.55 | 52.63 |
Stock-Based Compensation | 902.67 | 867.79 | 781.94 | 1,170 | 786.5 |
Other Operating Activities | -84,234 | -5,144 | -972.54 | 22,514 | 21,534 |
Change in Accounts Receivable | 4.16 | 1.92 | -1.87 | -0.6 | - |
Change in Accounts Payable | - | - | -3.45 | -850.67 | 802.53 |
Change in Other Net Operating Assets | 6,452 | 9,860 | -7,415 | -5.32 | -3,037 |
Operating Cash Flow | -52,158 | -35,989 | -11,282 | 94,244 | -41,092 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -582.18 | -696.27 | -1,264 | -1,126 | -796.13 |
Sale of Property, Plant & Equipment | 9.09 | - | - | 47 | - |
Sale (Purchase) of Real Estate | - | - | - | 1,796 | - |
Investment in Securities | 12,045 | -27,628 | -97,197 | 262.76 | 27,758 |
Other Investing Activities | -0 | -0 | -0 | -3,405 | -265.99 |
Investing Cash Flow | 11,472 | -28,324 | -98,460 | -2,426 | 26,701 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Repaid | - | -887.52 | -1,017 | -2,281 | -1,394 |
Net Debt Issued (Repaid) | -984.9 | -887.52 | -1,017 | -2,281 | -1,394 |
Issuance of Common Stock | 4,477 | 49,567 | 178.5 | - | - |
Other Financing Activities | 73.22 | -0 | - | -145.8 | - |
Financing Cash Flow | 148,565 | 48,679 | -838.32 | 23,573 | -1,394 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -15.01 | -1.52 | 3,622 | -8.15 | -81.88 |
Net Cash Flow | 107,864 | -15,635 | -106,959 | 115,383 | -15,866 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -52,740 | -36,685 | -12,545 | 93,117 | -41,888 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -130052.37% | -155680.70% | -60.01% | 68.76% | -55173.99% |
Free Cash Flow Per Share | -2477.25 | -1762.70 | -926.66 | 6184.75 | -9106.02 |
Levered Free Cash Flow | -33,182 | -19,893 | -10,472 | 59,189 | - |
Unlevered Free Cash Flow | -32,001 | -18,717 | -9,351 | 59,704 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 1,882 | 1,875 | 1,788 | 813.28 | 75.37 |
Cash Income Tax Paid | - | 478.59 | -449.93 | 329.15 | 18.55 |
Change in Working Capital | 6,456 | 9,862 | -7,420 | -856.59 | -2,235 |